|Articles|October 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Gene Discovery May Unlock Key to Obesity Syndrome

Author(s)Susan Farley

Scientists in the United States, Great Britain, and Canada were able to identify the last of 8 genes known to contribute to Bardet-Biedl syndrome (BBS), a rare disorder that combines the common problems of obesity, learning difficulties, diabetes, and asthma. The researchers think that the gene, known as BBS3/ARL6, can be used to understand the other BBS proteins and what causes BBS and, by extension, obesity and other BBS-related problems.

Articles in this issue

about 21 years ago

COMPOUNDING HOTLINE

about 21 years ago

Cardinal Introduces PatientPAK 340B

about 21 years ago

about 21 years ago

Government Plans Attack on Obesity

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME